Showing results (491-500 of 521) with videos related to
Sort By:
Pageof 53
Frontiers in Immunology|February 28, 2022
Pre-COVID-19 Immunity to Common Cold Human Coronaviruses Induces a Recall-Type IgG Response to SARS-CoV-2 Antigens Without Cross-NeutralisationMakoto Miyara, Melissa Saichi, Delphine Sterlin, et al.Journal of Autoimmunity|September 20, 2022
Prevalence, characteristics and outcome of cardiac manifestations in critically-ill antiphospholipid syndrome patientsLévi-Dan Azoulay, Marc Pineton de Chambrun, Romaric Larcher, et al.Critical Care Medicine|June 17, 2017
The Clinical Picture of Severe Systemic Capillary-Leak Syndrome Episodes Requiring ICU AdmissionMarc Pineton de Chambrun, Charles-Edouard Luyt, François Beloncle, et al.The Journal of Allergy and Clinical Immunology|April 24, 2021
Distinct cytokine profiles associated with COVID-19 severity and mortalityKarim Dorgham, Paul Quentric, Mehmet Gökkaya, et al.Intensive Care Medicine|August 24, 2018
Prevalence and outcome of heparin-induced thrombocytopenia diagnosed under veno-arterial extracorporeal membrane oxygenation: a retrospective nationwide studyAntoine Kimmoun, Walid Oulehri, Romain Sonneville, et al.The Lancet. Child & Adolescent Health|September 19, 2024
Definitions of adverse events associated with extracorporeal membrane oxygenation in children: results of an international Delphi process from the ECMO-CENTRAL ARCPeta M A Alexander, Matteo Di Nardo, Alain Combes, et al.Clinical Rheumatology|July 29, 2024
Hematological features and alternate diagnoses in critically ill thrombotic antiphospholipid syndrome patientsLevi-Dan Azoulay, Thomas Frapard, Romaric Larcher, et al.BMJ Open|February 6, 2025
Infrared illumination for difficult peripheral venous catheterisation in critically ill adult patients: the prospective, randomised, multicentre ICARE trialRachida Ouedraogo, Aline Alves, Amélie Bruant, et al.Journal of the American College of Cardiology|July 2, 2016
Early High-Dose Erythropoietin Therapy After Out-of-Hospital Cardiac Arrest: A Multicenter, Randomized Controlled TrialAlain Cariou, Nicolas Deye, Benoît Vivien, et al.Arthritis & Rheumatology (Hoboken, N.J.)|November 9, 2023
Towards the Lowest Efficacious Dose: Results From a Multicenter Noninferiority Randomized Open-Label Controlled Trial Assessing Tocilizumab or Abatacept Injection Spacing in Rheumatoid Arthritis in RemissionJoanna Kedra, Philippe Dieudé, Caroline Giboin, et al.Pageof 53